世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0096
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・アデノシンデアミナーゼ欠損症（ADA）治療の市場動向
・企業の競争状況、市場シェア
・アデノシンデアミナーゼ欠損症（ADA）治療の種類別市場規模（アダーゲン、レブコビ）
・アデノシンデアミナーゼ欠損症（ADA）治療の用途別市場規模（病院、薬局）
・アデノシンデアミナーゼ欠損症（ADA）治療の北米市場規模2016-2027（アメリカ、カナダ）
・アデノシンデアミナーゼ欠損症（ADA）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・アデノシンデアミナーゼ欠損症（ADA）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アデノシンデアミナーゼ欠損症（ADA）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・アデノシンデアミナーゼ欠損症（ADA）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Leadiant Biosciences）
・結論

Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide.

Market Analysis and Insights: Global Adenosine Deaminase Deficiency Treatment Market
The global Adenosine Deaminase Deficiency Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adenosine Deaminase Deficiency Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adenosine Deaminase Deficiency Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adenosine Deaminase Deficiency Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adenosine Deaminase Deficiency Treatment market.

Global Adenosine Deaminase Deficiency Treatment Scope and Market Size
Adenosine Deaminase Deficiency Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Adenosine Deaminase Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Adagen
Revcovi

Segment by Application
Hospital
Pharmacy

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adenosine Deaminase Deficiency Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Adagen
1.2.3 Revcovi
1.3 Market by Application
1.3.1 Global Adenosine Deaminase Deficiency Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Adenosine Deaminase Deficiency Treatment Market Perspective (2016-2027)
2.2 Adenosine Deaminase Deficiency Treatment Growth Trends by Regions
2.2.1 Adenosine Deaminase Deficiency Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Adenosine Deaminase Deficiency Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Adenosine Deaminase Deficiency Treatment Industry Dynamic
2.3.1 Adenosine Deaminase Deficiency Treatment Market Trends
2.3.2 Adenosine Deaminase Deficiency Treatment Market Drivers
2.3.3 Adenosine Deaminase Deficiency Treatment Market Challenges
2.3.4 Adenosine Deaminase Deficiency Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Adenosine Deaminase Deficiency Treatment Players by Revenue
3.1.1 Global Top Adenosine Deaminase Deficiency Treatment Players by Revenue (2016-2021)
3.1.2 Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Adenosine Deaminase Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adenosine Deaminase Deficiency Treatment Revenue
3.4 Global Adenosine Deaminase Deficiency Treatment Market Concentration Ratio
3.4.1 Global Adenosine Deaminase Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adenosine Deaminase Deficiency Treatment Revenue in 2020
3.5 Adenosine Deaminase Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Adenosine Deaminase Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Adenosine Deaminase Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Adenosine Deaminase Deficiency Treatment Breakdown Data by Type
4.1 Global Adenosine Deaminase Deficiency Treatment Historic Market Size by Type (2016-2021)
4.2 Global Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Type (2022-2027)

5 Adenosine Deaminase Deficiency Treatment Breakdown Data by Application
5.1 Global Adenosine Deaminase Deficiency Treatment Historic Market Size by Application (2016-2021)
5.2 Global Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Adenosine Deaminase Deficiency Treatment Market Size (2016-2027)
6.2 North America Adenosine Deaminase Deficiency Treatment Market Size by Type
6.2.1 North America Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021)
6.2.2 North America Adenosine Deaminase Deficiency Treatment Market Size by Type (2022-2027)
6.2.3 North America Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2027)
6.3 North America Adenosine Deaminase Deficiency Treatment Market Size by Application
6.3.1 North America Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2021)
6.3.2 North America Adenosine Deaminase Deficiency Treatment Market Size by Application (2022-2027)
6.3.3 North America Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2027)
6.4 North America Adenosine Deaminase Deficiency Treatment Market Size by Country
6.4.1 North America Adenosine Deaminase Deficiency Treatment Market Size by Country (2016-2021)
6.4.2 North America Adenosine Deaminase Deficiency Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Adenosine Deaminase Deficiency Treatment Market Size (2016-2027)
7.2 Europe Adenosine Deaminase Deficiency Treatment Market Size by Type
7.2.1 Europe Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021)
7.2.2 Europe Adenosine Deaminase Deficiency Treatment Market Size by Type (2022-2027)
7.2.3 Europe Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2027)
7.3 Europe Adenosine Deaminase Deficiency Treatment Market Size by Application
7.3.1 Europe Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2021)
7.3.2 Europe Adenosine Deaminase Deficiency Treatment Market Size by Application (2022-2027)
7.3.3 Europe Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2027)
7.4 Europe Adenosine Deaminase Deficiency Treatment Market Size by Country
7.4.1 Europe Adenosine Deaminase Deficiency Treatment Market Size by Country (2016-2021)
7.4.2 Europe Adenosine Deaminase Deficiency Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size (2016-2027)
8.2 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Type
8.2.1 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Application
8.3.1 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Region
8.4.1 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Adenosine Deaminase Deficiency Treatment Market Size (2016-2027)
9.2 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Type
9.2.1 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2027)
9.3 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Application
9.3.1 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2027)
9.4 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Country
9.4.1 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Adenosine Deaminase Deficiency Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size (2016-2027)
10.2 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Type
10.2.1 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Application
10.3.1 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Country
10.4.1 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Leadiant Biosciences
11.1.1 Leadiant Biosciences Company Details
11.1.2 Leadiant Biosciences Business Overview
11.1.3 Leadiant Biosciences Adenosine Deaminase Deficiency Treatment Introduction
11.1.4 Leadiant Biosciences Revenue in Adenosine Deaminase Deficiency Treatment Business (2016-2021)
11.1.5 Leadiant Biosciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Adenosine Deaminase Deficiency Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Adagen
Table 3. Key Players of Revcovi
Table 4. Global Adenosine Deaminase Deficiency Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Adenosine Deaminase Deficiency Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Adenosine Deaminase Deficiency Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Adenosine Deaminase Deficiency Treatment Market Share by Regions (2016-2021)
Table 8. Global Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Adenosine Deaminase Deficiency Treatment Market Share by Regions (2022-2027)
Table 10. Adenosine Deaminase Deficiency Treatment Market Trends
Table 11. Adenosine Deaminase Deficiency Treatment Market Drivers
Table 12. Adenosine Deaminase Deficiency Treatment Market Challenges
Table 13. Adenosine Deaminase Deficiency Treatment Market Restraints
Table 14. Global Adenosine Deaminase Deficiency Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Adenosine Deaminase Deficiency Treatment Market Share by Players (2016-2021)
Table 16. Global Top Adenosine Deaminase Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adenosine Deaminase Deficiency Treatment as of 2020)
Table 17. Ranking of Global Top Adenosine Deaminase Deficiency Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Adenosine Deaminase Deficiency Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Adenosine Deaminase Deficiency Treatment Product Solution and Service
Table 21. Date of Enter into Adenosine Deaminase Deficiency Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Adenosine Deaminase Deficiency Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Adenosine Deaminase Deficiency Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Adenosine Deaminase Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Adenosine Deaminase Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Adenosine Deaminase Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Adenosine Deaminase Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Adenosine Deaminase Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Adenosine Deaminase Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Adenosine Deaminase Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Adenosine Deaminase Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Adenosine Deaminase Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Adenosine Deaminase Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Adenosine Deaminase Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Adenosine Deaminase Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Leadiant Biosciences Company Details
Table 62. Leadiant Biosciences Business Overview
Table 63. Leadiant Biosciences Adenosine Deaminase Deficiency Treatment Product
Table 64. Leadiant Biosciences Revenue in Adenosine Deaminase Deficiency Treatment Business (2016-2021) & (US$ Million)
Table 65. Leadiant Biosciences Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adenosine Deaminase Deficiency Treatment Market Share by Type: 2020 VS 2027
Figure 2. Adagen Features
Figure 3. Revcovi Features
Figure 4. Global Adenosine Deaminase Deficiency Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Pharmacy Case Studies
Figure 7. Adenosine Deaminase Deficiency Treatment Report Years Considered
Figure 8. Global Adenosine Deaminase Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Adenosine Deaminase Deficiency Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Adenosine Deaminase Deficiency Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Adenosine Deaminase Deficiency Treatment Market Share by Regions (2022-2027)
Figure 12. Global Adenosine Deaminase Deficiency Treatment Market Share by Players in 2020
Figure 13. Global Top Adenosine Deaminase Deficiency Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adenosine Deaminase Deficiency Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Adenosine Deaminase Deficiency Treatment Revenue in 2020
Figure 15. Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Adenosine Deaminase Deficiency Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Adenosine Deaminase Deficiency Treatment Market Share by Type (2016-2027)
Figure 19. North America Adenosine Deaminase Deficiency Treatment Market Share by Application (2016-2027)
Figure 20. North America Adenosine Deaminase Deficiency Treatment Market Share by Country (2016-2027)
Figure 21. United States Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Adenosine Deaminase Deficiency Treatment Market Share by Type (2016-2027)
Figure 25. Europe Adenosine Deaminase Deficiency Treatment Market Share by Application (2016-2027)
Figure 26. Europe Adenosine Deaminase Deficiency Treatment Market Share by Country (2016-2027)
Figure 27. Germany Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Adenosine Deaminase Deficiency Treatment Market Share by Region (2016-2027)
Figure 37. China Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Adenosine Deaminase Deficiency Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Adenosine Deaminase Deficiency Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Adenosine Deaminase Deficiency Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Adenosine Deaminase Deficiency Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Adenosine Deaminase Deficiency Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Leadiant Biosciences Revenue Growth Rate in Adenosine Deaminase Deficiency Treatment Business (2016-2021)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Global Adenosine Deaminase Deficiency Market Size, Status and Forecast 2021-2027
QYR2104Z0094 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のアデノシンデアミナーゼ欠損症（ADA）治療薬市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z0095 2021年4月 99Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2309 2021年4月 97Pages
QYResearch社発行の本調査資料では、第IX因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病B、血友病B阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のビタミンD欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Vitamin D Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5957 2021年4月 92Pages
QYResearch社発行の本調査資料では、ビタミンD欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビタミンD2、ビタミンD3）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の成長ホルモン欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Growth Hormone Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2639 2021年4月 90Pages
QYResearch社発行の本調査資料では、成長ホルモン欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、組換えヒト成長ホルモン、ヒト下垂体抽出物、手術）、用途別市場規模（病院、診療所、在宅ケア）、主要地域別市場規模（北米、ア...

世界のチロシンヒドロキシラーゼ欠損症治療市場規模・現状・予測（2021年-2027年）

Global Tyrosine Hydroxylase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5773 2021年4月 91Pages
QYResearch社発行の本調査資料では、チロシンヒドロキシラーゼ欠損症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（投薬、言語療法、その他）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨ...

世界のCARD9欠乏症治療市場規模・現状・予測（2021年-2027年）

Global CARD9 Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1109 2021年4月 96Pages
QYResearch社発行の本調査資料では、CARD9欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（全身性抗真菌性感染症、表面的抗真菌性感染症）、用途別市場規模（病院、クリニック、薬局、その他）、主要地域別市場規模（北米、アメリカ、...

世界のCARD9欠乏症治療市場規模・現状・予測（2021年-2027年）

世界の第VIII因子欠乏症治療市場規模・現状・予測（2021年-2027年）

Global Factor VIII Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2310 2021年4月 128Pages
QYResearch社発行の本調査資料では、第VIII因子欠乏症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血友病A薬、血友病A阻害剤治療、フォンウィルブランド病治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のアデノシンデアミナーゼ欠損症（ADA）市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Market The global Adenosine Deaminase Deficiency market size is …
世界のアデノシンデアミナーゼ欠損症（ADA）治療薬市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Therapeutic Market The global Adenosine Deaminase Deficiency The…
世界の第IX因子欠乏症治療市場規模・現状・予測（2021年-2027年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…
世界のビタミンD欠乏症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vitamin D Deficiency Treatment Market The global Vitamin D Deficiency Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data int…
世界の成長ホルモン欠乏症治療市場規模・現状・予測（2021年-2027年） Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. The primary factor contributing to the growth of global growth hormone deficie…